Check the brokerage calls and comments on the stocks in action. Today we cover Aurobindo Pharma, Nazara Tech, LIC among others following their Q4 results.
Nazara announced that it is either merging or closing entities that do not align with its future vision, including Nazara Bangladesh and NZ Mobile Nigeria.
Sanjiv Bhasin from IIFL Securities provides insights on market trends, highlighting the performance of key banks like HDFC, Kotak, ICICI, and Axis. He recommends focusing on IDFC First, Dhanlaxmi Bank, SBI Life, Grasim, LIC, GIC, and New India Assurance for potential growth. Bhasin also says that in pharma, Divi s is one of the best contract pharming companies and it is regaining its position but he would put his money on Lupin.
Mitter Infotech LLP sells 6.38% stake in Nazara Technologies to Plutus Wealth Management, providing liquidity for promoters while retaining control. Nazara reports 43% increase in quarterly profit after tax.